Research suggests that beta-alanine supplementation provides little to no measurable benefit for muscle recovery, based on the available evidence linked to this topic. The most directly relevant study — a controlled trial examining 28 days of beta-alanine supplementation in untrained young adults — found no improvement over placebo in any recovery measure assessed, including muscle soreness, perceived exertion, or blood markers of muscle damage at 24, 48, or 72 hours following high-intensity resistance exercise. A 2023 review touching on beta-alanine in the context of athlete nutrition and gut microbiota acknowledged the supplement's ergogenic interest but noted that evidence remains limited, particularly regarding how supplementation strategies interact with broader physiological systems relevant to recovery. It is worth noting that the remaining studies provided were unrelated to beta-alanine or muscle recovery, leaving the evidence base here narrow, and readers should be aware that conclusions drawn from a single controlled trial in untrained individuals may not generalize to other populations or training contexts.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Effects of beta-alanine supplementation on muscle function during recovery fr... | Other | 2019 | — | 100 |
| Different Approaches to Ergogenic, Pre-, and Probiotic Supplementation in Spo... | Review | 2023 | — | 95 |
| Taurine Protects C2C12 Myoblasts From Impaired Cell Proliferation and Myotube... | Other | 2021 | Neutral | 90 |
| Altered systemic bioenergetic reserve in chronic kidney disease predisposes h... | Other | 2024 | Neutral | 85 |
| An immunocompetent murine model of virus-elicited liver fibrosis and hepatoce... | Other | 2025 | Neutral | 80 |
| Targeting Troponin I Phosphorylation for Precision Treatment of Diastolic Dys... | Other | 2025 | Neutral | 75 |
| Biological landscape of acute illness in children in sub-Saharan Africa and S... | Other | 2025 | Neutral | 70 |
| Discovery of phage defense systems through component modularity networks | Other | 2025 | Neutral | 65 |
| Structural basis for binding of RILPL1 to TMEM55B reveals a lysosomal platfor... | Other | 2025 | Neutral | 60 |
| Circulating low-molecular-weight (poly)phenol metabolites in the brain: unvei... | Other | 2024 | Neutral | 55 |
| Ribosomal modification by BUD23 drives selective translational control over e... | Other | 2025 | Neutral | 50 |
| Long COVID: G Protein-Coupled Receptors (GPCRs) responsible for persistent po... | Other | 2022 | Neutral | 45 |
| The sleep quality- and myopia-linked PDE11A-Y727C variant impacts neural phys... | Other | 2023 | Neutral | 40 |
| Detection and characterization of novel luchacoviruses, genus<i>Alphacoronavi... | Other | 2023 | Neutral | 35 |
| Identifying The “Core” Transcriptome of SARS-CoV-2 Infected Cells | Other | 2021 | Neutral | 30 |
| Mild uncoupling of mitochondria synergistically enhances senolytic specificit... | Other | 2023 | Neutral | 25 |
| Host-Microbiome Associations in Saliva Predict COVID-19 Severity | Other | 2023 | Neutral | 20 |
| Genetic diversity of <i>Staphylococcus aureus</i> wall teichoic acid glycosyl... | Other | 2022 | Neutral | 15 |